Skip to main content
Top
Published in: Urolithiasis 6/2003

01-12-2003

Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type-p53 but not in p53-mutated bladder cancer cells

Authors: Nobuyuki Hinata, Toshiro Shirakawa, Zhujun Zhang, Akira Matsumoto, Masato Fujisawa, Hiroshi Okada, Sadao Kamidono, Akinobu Gotoh

Published in: Urolithiasis | Issue 6/2003

Login to get access

Abstract

Purpose. It has been reported in several studies that the absence in cancer cells of the p53 tumor suppressor gene, mutations of which are frequently found in bladder cancer, increases their resistance to ionizing radiation. Other studies, however, suggest that mutations of the p53 gene could increase the radiosensitivity of cancer cells, although the evidence is still inconclusive. In the present study, we investigated the relationship between p53 status and radiation response in five different bladder cancer cell lines. Materials and Methods. Five different human bladder cancer cell lines (KK47: with wt-p53, RT4: with wt-p53, T24: with mutated p53, 5637: with mutated p53, UM-UC-3: with mutated p53) were used in the study. Cells were irradiated with 0, 2, 4, 6 or 8 Gy, then trypsinized and re-plated for clonogenic survival assay, quantitative RT-PCR assay, flow-cytometry analysis and TUNEL assay. Results. The clonogenic assay demonstrated that KK47 and RT4 had significantly higher radiosensitivity than other cell lines. Quantitative RT-PCR analysis showed that radiation induced increased expression of p53, Bax, and p21 mRNA in KK47 and RT4. After irradiation, G1 cell-cycle arrest was observed in KK47 and RT4 under flow cytometry analysis, while T24, 5637, and UM-UC-3 showed an increase in the proportion of G2 cells. Increased cell apoptosis was also observed under TUNEL assay in KK47 and RT4, but not in other cell lines. Conclusions: It was demonstrated that ionizing radiation induces p53-dependent cell apoptosis in bladder cancer cells with wt-p53 but not in those with mutated p53.
Literature
1.
go back to reference Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ (1993) p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143: 389 Esrig D, Spruck CH 3rd, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ (1993) p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143: 389
2.
go back to reference Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, Jones J, Balcerzak SP, Crawford ED, Grossman HB (2001) Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a southwest oncology group study. J Urol 165:56PubMed Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, Jones J, Balcerzak SP, Crawford ED, Grossman HB (2001) Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a southwest oncology group study. J Urol 165:56PubMed
3.
go back to reference Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706PubMed Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706PubMed
4.
go back to reference Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304PubMed Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304PubMed
5.
go back to reference Hall PA, McKee PH, Menage HD, Dover R, Lane DP (1993) High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8:203PubMed Hall PA, McKee PH, Menage HD, Dover R, Lane DP (1993) High levels of p53 protein in UV-irradiated normal human skin. Oncogene 8:203PubMed
6.
go back to reference Lee JM, Bernstein A (1993) p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90:5742PubMed Lee JM, Bernstein A (1993) p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90:5742PubMed
7.
go back to reference Zhan Q, Bae I, Kastan MB, Fornace AJ Jr (1994) The p53-dependent gamma-ray response of GAAD45. Cancer Res 54:2755PubMed Zhan Q, Bae I, Kastan MB, Fornace AJ Jr (1994) The p53-dependent gamma-ray response of GAAD45. Cancer Res 54:2755PubMed
8.
go back to reference Concin N, Zeillinger C, Stimpfel M, Schiebel I, Tong D, Wolff U, Reiner A, Leodolter S, Zeillinger R (2000) p53-dependent radioresistance in ovarian carcinoma cell lines. Cancer Lett 150: 91 Concin N, Zeillinger C, Stimpfel M, Schiebel I, Tong D, Wolff U, Reiner A, Leodolter S, Zeillinger R (2000) p53-dependent radioresistance in ovarian carcinoma cell lines. Cancer Lett 150: 91
9.
go back to reference Maebayashi K, Mitsuhashi N, Takahashi T, Sakurai H, Niibe H (1999) p53 mutation decreased radiosensitivity in rat yolk sac tumor cell lines. Int J Oncol Biol Phys 44:677CrossRef Maebayashi K, Mitsuhashi N, Takahashi T, Sakurai H, Niibe H (1999) p53 mutation decreased radiosensitivity in rat yolk sac tumor cell lines. Int J Oncol Biol Phys 44:677CrossRef
10.
go back to reference Biard DS, Martin M, Rhun YL, Duthu A, Lefaix JL, May E, May P (1994) Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryoepithelial cells during neoplastic development. Cancer Res 54:3361PubMed Biard DS, Martin M, Rhun YL, Duthu A, Lefaix JL, May E, May P (1994) Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryoepithelial cells during neoplastic development. Cancer Res 54:3361PubMed
11.
go back to reference McIlwrath AJ, Vasey PA, Ross GM, Brown R (1994) Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54:3718PubMed McIlwrath AJ, Vasey PA, Ross GM, Brown R (1994) Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Res 54:3718PubMed
12.
go back to reference Kawashima K, Mihara K, Usuki H, Shimizu N, Namba M (1995) Transfected mutant p53 gene increases X-ray induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells. Int J Cancer 61:76PubMed Kawashima K, Mihara K, Usuki H, Shimizu N, Namba M (1995) Transfected mutant p53 gene increases X-ray induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells. Int J Cancer 61:76PubMed
13.
go back to reference Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ Jr (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10:1053PubMed Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ Jr (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene 10:1053PubMed
14.
go back to reference Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR (1993) p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53: 3667PubMed Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR (1993) p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53: 3667PubMed
15.
go back to reference Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB (1993) Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 53:4164PubMed Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB (1993) Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res 53:4164PubMed
16.
go back to reference Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855PubMed Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855PubMed
17.
go back to reference Rieger KM, Little AF, Swart JM, Kastrinakis WV, Fitzgerald JM, Hess DT, Libertino JA, Summerhayes IC (1995) Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer 72:683PubMed Rieger KM, Little AF, Swart JM, Kastrinakis WV, Fitzgerald JM, Hess DT, Libertino JA, Summerhayes IC (1995) Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer 72:683PubMed
18.
go back to reference Cooper MJ, Haluschak JJ, Johnson D, Schwartz S, Morrison LJ, Lippa M, Hatzivassiliou G, Tan J (1994) p53 mutations in bladder carcinoma cell lines. Oncol Res 6:569PubMed Cooper MJ, Haluschak JJ, Johnson D, Schwartz S, Morrison LJ, Lippa M, Hatzivassiliou G, Tan J (1994) p53 mutations in bladder carcinoma cell lines. Oncol Res 6:569PubMed
19.
go back to reference Kimiya K, Naito S, Soejima T, Sakamoto N, Kotoh S, Kumazawa J, Tsuruo T (1992) Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. J Urol 148:441PubMed Kimiya K, Naito S, Soejima T, Sakamoto N, Kotoh S, Kumazawa J, Tsuruo T (1992) Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. J Urol 148:441PubMed
20.
go back to reference Shirakawa T, Sasaki R, Gardner TA, Kao C, Zhang ZJ, Sugimura K, Matsuo M, Kamidono S, Gotoh A (2001) Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells. Int J Cancer 94: 282CrossRefPubMed Shirakawa T, Sasaki R, Gardner TA, Kao C, Zhang ZJ, Sugimura K, Matsuo M, Kamidono S, Gotoh A (2001) Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells. Int J Cancer 94: 282CrossRefPubMed
21.
go back to reference Kathryn B, Dao P, Chester BW (1999) Real-time quantitative polymerase chain reaction to assess gene transfer. Hum Gene Ther 10:2559CrossRefPubMed Kathryn B, Dao P, Chester BW (1999) Real-time quantitative polymerase chain reaction to assess gene transfer. Hum Gene Ther 10:2559CrossRefPubMed
23.
go back to reference Shipman R, Schraml P, Moch H (1997) p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancer. Int J Oncol 10:801 Shipman R, Schraml P, Moch H (1997) p53 protein accumulation and p53 gene alterations (RFLP, VNTR and p53 gene mutations) in non-invasive versus invasive human transitional bladder cancer. Int J Oncol 10:801
24.
go back to reference Berggren P, Steineck G, Adolfsson J, Hansson J, Jansson O, Larsson P, Sandstedt B, Wijkstrom H, Hemminki K (2001) p53 mutations in urinary bladder cancer. Br J Cancer 84:1505CrossRefPubMed Berggren P, Steineck G, Adolfsson J, Hansson J, Jansson O, Larsson P, Sandstedt B, Wijkstrom H, Hemminki K (2001) p53 mutations in urinary bladder cancer. Br J Cancer 84:1505CrossRefPubMed
25.
go back to reference Xu X, Stower MJ, Reid IN, Garner RC, Burns PA (1997) A hot spot for p53 mutation in transitional cell carcinoma of the bladder: clues to the etiology of bladder cancer. Cancer Epidemiol Biomarkers Prev 6:611PubMed Xu X, Stower MJ, Reid IN, Garner RC, Burns PA (1997) A hot spot for p53 mutation in transitional cell carcinoma of the bladder: clues to the etiology of bladder cancer. Cancer Epidemiol Biomarkers Prev 6:611PubMed
26.
go back to reference Wu CS, Pollack A, Czerniak B, Chyle V, Zagars GK, Dinney CP, Hu SX, Benedict WF (1996) Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy. Urology 47:305CrossRefPubMed Wu CS, Pollack A, Czerniak B, Chyle V, Zagars GK, Dinney CP, Hu SX, Benedict WF (1996) Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy. Urology 47:305CrossRefPubMed
27.
go back to reference Osen I, Fossa SD, Majak B, Rotterud R, Berner A (1998) Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study. Br J Urol 81:862PubMed Osen I, Fossa SD, Majak B, Rotterud R, Berner A (1998) Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study. Br J Urol 81:862PubMed
28.
go back to reference Brachman RK, Vidal M, Boeke JD (1996) Dominant-negative p53 mutations selected in yeast hit cancer hot spots. Proc Natl Acad Sci USA 93:4091CrossRefPubMed Brachman RK, Vidal M, Boeke JD (1996) Dominant-negative p53 mutations selected in yeast hit cancer hot spots. Proc Natl Acad Sci USA 93:4091CrossRefPubMed
29.
go back to reference Isaacs JS, Chiao C, Merrick BA, Selkirk JK, Barrett JC, Weissman BE (1997) p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. Cancer Res 57:2986PubMed Isaacs JS, Chiao C, Merrick BA, Selkirk JK, Barrett JC, Weissman BE (1997) p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line. Cancer Res 57:2986PubMed
30.
go back to reference Russell KJ, Wiens LW, Demers GW, Galloway DA, Plon SE, Groudine M (1995) Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint competent cells. Cancer Res 55:1639PubMed Russell KJ, Wiens LW, Demers GW, Galloway DA, Plon SE, Groudine M (1995) Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint competent cells. Cancer Res 55:1639PubMed
31.
go back to reference Siles E, Villalobos M, Valenzuela MT, Nunez MI, Gordon A, McMillan TJ, Pedraza V, Ruiz de Almodovar JM (1996) Relationship between p53 status and radiosensitivity in human tumor cell lines. Br J Cancer 73:581PubMed Siles E, Villalobos M, Valenzuela MT, Nunez MI, Gordon A, McMillan TJ, Pedraza V, Ruiz de Almodovar JM (1996) Relationship between p53 status and radiosensitivity in human tumor cell lines. Br J Cancer 73:581PubMed
32.
go back to reference Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ (1996) DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci USA 93:15209CrossRefPubMed Pellegata NS, Antoniono RJ, Redpath JL, Stanbridge EJ (1996) DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci USA 93:15209CrossRefPubMed
33.
go back to reference Friedlander P, Haupt Y, Prives C, Oren M (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol 16:4961PubMed Friedlander P, Haupt Y, Prives C, Oren M (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol 16:4961PubMed
34.
go back to reference Slaton JW, Benedict WF, Dinney CPN (2001) p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology 57:852CrossRefPubMed Slaton JW, Benedict WF, Dinney CPN (2001) p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy. Urology 57:852CrossRefPubMed
35.
go back to reference Lowe SW, Ruley HE (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7:535PubMed Lowe SW, Ruley HE (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev 7:535PubMed
36.
go back to reference Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 57PubMed Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 57PubMed
37.
go back to reference Chen X, Ko LJ, Jayaraman L, Prives C (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438PubMed Chen X, Ko LJ, Jayaraman L, Prives C (1996) p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 10:2438PubMed
38.
go back to reference Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293PubMed Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293PubMed
39.
go back to reference Imai R, Akimoto T, Maebayashi K, Ishikawa H, Sakurai H, Saitoh J, Hasegawa M, Mitsuhashi N, Nakano T (2002) Signal transduction pathway to low-dose radiation-induced apoptosis in peripheral PNET cells. Anticancer Res 22:2741PubMed Imai R, Akimoto T, Maebayashi K, Ishikawa H, Sakurai H, Saitoh J, Hasegawa M, Mitsuhashi N, Nakano T (2002) Signal transduction pathway to low-dose radiation-induced apoptosis in peripheral PNET cells. Anticancer Res 22:2741PubMed
40.
go back to reference Ito T, Fujieda S, Tsuzuki H, Sunaga H, Fukuda M, Saito H (2001) Appearance of bax protein after preoperative chemoradiotherapy is a prognostic factor in maxillary cancer. Acta Otolaryngol 121:967CrossRefPubMed Ito T, Fujieda S, Tsuzuki H, Sunaga H, Fukuda M, Saito H (2001) Appearance of bax protein after preoperative chemoradiotherapy is a prognostic factor in maxillary cancer. Acta Otolaryngol 121:967CrossRefPubMed
Metadata
Title
Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type-p53 but not in p53-mutated bladder cancer cells
Authors
Nobuyuki Hinata
Toshiro Shirakawa
Zhujun Zhang
Akira Matsumoto
Masato Fujisawa
Hiroshi Okada
Sadao Kamidono
Akinobu Gotoh
Publication date
01-12-2003
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 6/2003
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-003-0355-9

Other articles of this Issue 6/2003

Urolithiasis 6/2003 Go to the issue

Acknowledgement to Referees

Acknowledgement to Referees